Dynein intermediate chain 1 (DYNC1I1) (P74)

Dynein intermediate chain 1, frequently referred to as P74 or p74, is a critical subunit of the cytoplasmic dynein-1 motor complex responsible for retrograde transport along microtubules. It serves as a key adapter that links the dynein motor to specific intracellular cargoes, including mitochondria, lysosomes, and signaling complexes, thereby regulating their spatial distribution and movement within the cell [11, 44]. P74 plays a vital role in maintaining neuronal health by facilitating the transport of mitochondria from synaptic terminals back to the cell body; its dysfunction or detachment from cargo is a recognized mechanism in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease [10, 13, 44]. Additionally, P74 is involved in the rapid reorganization of the cytoskeleton during T-cell receptor activation, where it drives the translocation of the microtubule-organizing center (MTOC) to the immunological synapse to enable effective immune responses [11, 47, 49]. While not yet a target for approved small-molecule drugs, P74 is a significant focus of research into therapeutic strategies for restoring axonal transport and modulating immune cell polarity in diseases like multiple sclerosis and various tauopathies [10, 47].

Other names

Dynein intermediate chain 1Cytoplasmic dynein 1 intermediate chain 1p74DIC1DNCI1

Dynein intermediate chain 1 (P74) acts as a scaffold within the cytoplasmic dynein motor complex, mediating the attachment of the motor to various intracellular cargoes, such as mitochondria and lytic granules, and facilitating their retrograde transport along microtubules [10, 44, 49]. In neurodegenerative contexts like Alzheimer's disease, the detachment of P74 from mitochondria—often induced by mutant proteins like UbB+1—leads to impaired axonal transport and neuronal degeneration [10, 13]. In immunology, P74 is essential for the translocation of the microtubule-organizing center (MTOC) toward the immunological synapse during T-cell activation, a process critical for directed secretion of lytic mediators [11, 47].